Volume 10, Number 8—August 2004
Research
Pharmacy Data for Tuberculosis Surveillance and Assessment of Patient Management
Table 2
Reasons why non-TB cases met screening criteria | Plan A (%) | Plan B (%) | Plan C (%) | Total (%) |
---|---|---|---|---|
Suspected active TB, full course of therapy | 7 (13) | 0 | 8 (9) | 15 (10) |
Suspected active TB, empiric therapy discontinued | 12 (22) | 0 | 35 (38) | 47 (31) |
Treatment of latent TB infection | 8 (14) | 3 (43) | 10 (11) | 21 (14) |
Other mycobacterial infections | 26 (47) | 4 (57) | 33 (36) | 63 (41) |
Other or unknown | 2 (4) | 0 | 5 (5) | 7 (4) |
Total | 55 | 7 | 91 | 153 |
Page created: June 14, 2011
Page updated: June 14, 2011
Page reviewed: June 14, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.